TABLE 2.
Category | % Sensitivity [95% CI] | % Specificity [95% CI] |
---|---|---|
Treatment failures (1 mo posttreatment) | 86 [42–99] (6/7) | 33 [2–88] (1/3) |
Recurrences (3, 6, or 9 mo posttreatment) | 68 [44–86] (13/19) | 100 [31–100] (3/3) |
All treatment failures and recurrences (at any follow-up point up to 9 mo posttreatment) | 73 [52–88] (19/26) | 67 [24–94] (4/6) |